The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.

Equine Vet J · 2019 · PMC6850029 · PMID 30815897

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

4 evaluated adipose‐derived stromal vascular fraction and bone marrow‐derived MSCs for treatment of OA, and reported a greater improvement during various evaluations with bone marrow‐derived MSCs compared with placebo treatment and adipose‐derived stromal vascular fraction cells, but the observed effects did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.